
Sanjay Kumar Jain MD
Professor of Pediatrics, Radiology & Radiological Science and International Health Vice Chair for Basic & Translational Research, Department of Pediatrics Director, Center for Infection and Inflammation Imaging Research
Join to View Full Profile
200 North Wolfe StreetRubenstein BLDG Lower LevelBaltimore, MD 21287
Phone+1 443-997-5437
Fax+1 410-955-1491
Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sanjay K Jain, M.D. is Professor of Pediatrics, Radiology & Radiological Sciences and International Health at the Johns Hopkins University. He directs the Center for Infection and Inflammation Imaging Research and is a member of the Center for TB Research at Johns Hopkins. Dr. Jain is also the Vice Chair for Basic & Translational Research in the Department of Pediatrics. His primary research interests include the development of novel molecular imaging technologies for bacterial infections, pediatric tuberculosis (TB), and TB meningitis. Dr. Jain’s laboratory conducts animal and human studies to develop and evaluate novel radiopharmaceutical imaging methods (CT, PET, SPECT, MRI) to understand disease pathogenesis (e.g. study antimicrobial pharmacokinetics at infection sites) and pathogen-specific imaging diagnostics. Several novel tracers developed in his laboratory are now being tested in first-in-human studies. For example, they have performed first-in-human studies using a radiolabeled version of rifampin and pretomanid (important antibiotics) in humans with TB or S. aureus infections to test whether these antibiotics achieves adequate levels at the infection sites. Similarly, his group is evaluating novel pathogen-specific PET tracers to noninvasively detect invasive bacterial and fungal infections in patients. Dr. Jain is funded though several grants. Notably, he is also the recipient of the prestigious NIH Director’s New Innovator Award (2009) and the NIH Director’s Transformative Research Award (2014). Dr. Jain is the past chair (2014-2021) and a founding member of the Infectious Diseases subgroup and current board member and Executive committee member of the World Molecular Imaging Society. He serves as a reviewer for multiple scientific journals and NIH study panels.
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Infectious Diseases, 2002 - 2005
- Tufts Medical CenterResidency, Pediatrics, 2000 - 2002
- Penn State Milton S Hershey Medical CenterInternship, Pediatrics, 1999 - 2000
- All India Institute of Medical SciencesClass of 1999
Certifications & Licensure
- MD State Medical License 2005 - 2026
- PA State Medical License 1999 - 2000
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- NIH Director's Transformative Research Award National Institutes of Health, 2014
- NIH Director's New Innovator Award National Institutes of Health, 2009
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Timeliness of Immunization and Compliance Assessment Study Start of enrollment: 2018 Apr 25
- Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET Start of enrollment: 2023 May 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- DynamicC-PABA PET/CT for Visualizing PulmonaryInfections.Yuderleys Masias-Leon, Carlos E Ruiz-Gonzalez, Oscar J Nino-Meza, Medha Singh, Mona O Sarhan
American Journal of Respiratory and Critical Care Medicine. 2025-03-28 - Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis.Medha Singh, Mona O Sarhan, Nerketa N L Damiba, Alok K Singh, Andres Villabona-Rueda
Nature Communications. 2025-03-27 - 3 citationsDynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs.Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh
Nature Communications. 2024-08-14
Journal Articles
- Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivoAshbaugh AG, Jiang X, Zheng J, Tsai AS, Kim WS, Thompson JM, Miller RJ, Shahbazian JH, Wang Y, Ordonez AA, Chang YS, Jain SK, Jones LC, Sterling RS, Mao HQ, Miller LS, Proc Natl Acad Sci U S A, 1/24/2016
- A Systematic Approach for Developing Bacteria-Specific Imaging TracersOrdonez AA, Weinstein EA, Bambarger LE, Saini V, Chang YS, DeMarco VP, Klunk M, Urbanowski ME, Moulton KL, Murawski AM, Pokkali S, Kalinda AS, Jain SK, J Nucl Med, 1/15/2016
- The anti-fibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosisAhidjo BA, Maiga MC, Ihms EA, Maiga M, Ordonez AA, Cheung LS, Beck S, Andrade BB, Jain SK, Bishai WR, JCI Insight, 1/1/2016
- Join now to see all
Books/Book Chapters
Lectures
- Enhancing Health Care Access with Cellular TechnologyNational Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, MD - 1/1/2016
- Imaging pulmonary infectionsStevenage, UK - 1/1/2016
- Workshop: Development milestone: A road for competenceAbu Dhabi, UAE - 1/1/2016
- Join now to see all
Other Languages
- Hindi
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/sanjay-jain
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: